Product
Desmopressin
Aliases
MINIRIN® Injection
5 clinical trials
9 indications
Indication
Cerebrovascular StrokeIndication
Cerebrovascular AtherosclerosisIndication
Intracranial ArteriosclerosisIndication
Nocturnal PolyuriaIndication
Chronic Kidney DiseaseIndication
Acute Kidney InjuryIndication
BleedingIndication
SurgeryIndication
EnuresisClinical trial
A Single/Multiple Ascending Dose Phase 1 Study of the Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Human VolunteersStatus: Completed, Estimated PCD: 2020-09-14
Clinical trial
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet 25μg / 50μg in Treatment for Male Nocturia Due to Nocturnal PolyuriaStatus: Completed, Estimated PCD: 2023-09-30
Clinical trial
Bleeding Reduction in Acute and Chronic KidnEy patienTs Having Surgery (BRACKETS) Pilot TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Is Mirabegron 25 mg Safe and Effective in Treatment of Primary Nocturnal Enuresis as Regard Oral Desmopressin 120 mcg?Status: Recruiting, Estimated PCD: 2023-09-01
Clinical trial
Outcome of Adding Desmopressin to Tamsulosin for Treatment of Nocturnal Polyurea in Patients With Benign Prostatic ObstructionStatus: Recruiting, Estimated PCD: 2024-01-10